27

Opening and Awards Ceremony

Saturday, September 16, 14:30-16:00

Join us at a newly designed and exciting Opening and Awards Ceremony which will take place from 14:30-16:00 on Saturday, September 16.

This year’s Congress proceedings will start off with an Opening and Awards Ceremony that you won’t want to miss! A welcome address by CIRSE President Elias Brountzos, Local Host Committee Chairperson Poul Erik Andersen, and Scientific Programme Committee Chairperson Christoph Binkert will set the scene of our 32nd Congress. Following this, our keynote speaker, Prof. Sadek Beloucif, will give a fascinating presentation titled "Cure – Care – Coordination: Towards a New Medical Paradigm for Patients?". The final portion of the programme will be dedicated to presenting six prestigious awards, including the Award of Excellence and Innovation in IR, the CVIR Editor's Medal, three Distinguished Fellow awards, and the CIRSE Gold Medal.

Keynote Speaker: Sadek Beloucif

Prof. Beloucif's discussion will look at the importance of structuring medical education around the foundation of the patient-physician relationship in order to give patients the care they want and need. Alongside this talk, three interpretive dance pieces will take place exploring the concepts of "cure", "care" and "coordination".

CVIR Editor's Medal: Francisco Carnevale

Francisco Carnevale will win this year's CVIR Editor's Medal for the paper "Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis”.

CIRSE Gold Medal: Dierk Vorwerk

This year’s Gold Medallist is Dierk Vorwerk, who is currently the Chairman of the Department of Diagnostic and Interventional Radiology at the Klinikum Ingolstadt. Prof. Vorwerk has served as reviewer, consultant and editorial board member of many radiological and medical journals, including CVIR, in which he held the position of Editor-in-Chief from 2003 until this year. Prof. Vorwerk is a past president of CIRSE, having served in that position from 2000-2001. His laudation will be given by Johannes Lammer.

Distinguished Fellows: Yasuaki Arai, Mario Bezzi and Ernst-Peter K. Strecker

Award of Excellence and Innovation in IR:

Since its establishment in 2012, the Award of Excellence and Innovation in Interventional Radiology has been given to some of the most innovative physicians in the field.

This year, two winners have been chosen from among the 24 very deserving applicants; great innovators who have paved the way for a completely new strategy in acute ischemic stroke management with a ground-breaking invention and a high-class clinical trial.

At the CIRSE 2017 opening ceremony Hans Henkes will receive the award for the invention of the Solitaire Stent and the MR CLEAN trialists represented by Wim H. van Zwam will be honoured for the MR CLEAN Trial. 

Winner 2017
Hans Henkes, for the invention of the Solitaire™ Stent for intracranial stent thrombectomy

Prof. Hans Henkes from Germany has gained great reputation for his pioneering work in cerebral stent thrombectomy. In 2004, he invented the Solitaire™ Stent, which was initially designed for the treatment of cerebral aneurysms. Incidentally he found out that it could also be applied for the removal of intracranial thrombi and performed the first successful intracranial stent thrombectomy in Europe in 2008. This stent retriever represented a considerable improvement in acute ischemic stroke management compared to other thrombectomy devices available at that time. The SolitaireTM Stent became an international patent in 2004, followed by the US patent in 2014. It has since saved thousands of lives and prevented countless cases of stroke-related handicap.

About the invention

The Solitaire™ device is comprised of a nitinol scaffolding design attached to a guidewire. After being delivered through a micro catheter, it is deployed across a clot and removed along with the clot to enable revascularization of the occluded intracranial vessel.

If applied within 8 hours of symptom onset, the Solitaire™ can remove the thrombus from a large intracranial occlusion and restore blood flow to a degree that will allow nearly 70% relative improvement in functional outcomes at 90 days.

About the inventor

Since his graduation from medical school in 1987, Prof. Hans Henkes has held several clinical positions throughout Germany, including that of First Assistant Medical Director at the Clinic of Radiology and Neuroradiology at the Alfred Krupp Krankenhaus in Essen and that of Medical Director for Radiology and Neuroradiology at the Robert Janker Clinic in Bonn. Since 2007 he has been the Medical Director of the Neuroradiological Clinic at Stuttgart’s Katharinenhospital. He has published more than 240 articles, mostly focussing on neuroradiology, neurological diseases, neurodegeneration and intracranial aneurysms. His papers have been cited over 4,000 times. 

Winner 2017
The MR CLEAN Trialists, for the Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands represented by Wim H. van Zwam

About the MR CLEAN trial

The MR CLEAN trial, published to great acclaim in the New England Journal of Medicine on January 1, 2015, was the first randomized controlled trial showing a clear benefit of endovascular treatment in acute ischemic stroke. The 2-year outcome published on April 6, 2017, also in the NEJM, confirmed the beneficial effect of endovascular treatment.

Designed as a randomized controlled trial of intra-arterial treatment versus no intra-arterial treatment in patients with a proximal intracranial arterial occlusion, five hundred patients were randomized between December 2010 and April 2014 in 16 centres in the Netherlands. Functional outcome at 90 days as well as secondary clinical outcomes showed a clear benefit for the intervention group. Contrary to previous studies which could not demonstrate preferability of endovascular intervention over standard treatment, during the MR CLEAN trial the latest generation of thrombectomy devices (stent retrievers, including the Solitaire™ Stent) were used, significantly changing the outcome in favour of endovascular treatment. Within less than one year this has resulted in the worldwide adaptation of guidelines incorporating endovascular treatment as standard treatment.

About the MR CLEAN Trialists

The MR CLEAN trial is a joint interdisciplinary study comprising neurology, neuroradiology, radiology and interventional/neurointerventional radiology.

The MR CLEAN trialists include six principal investigators together with the three (shared) first authors from the Universities of Rotterdam, Amsterdam and Maastricht: Dr. Puck Franssen, Prof. Diederik Dippel and Prof. Aad van der Lugt from the Erasmus MC University Medical Center, Rotterdam; Dr. Olvert Berkhemer, Prof. Yvo Roos and Prof. Charles Majoie from the Academic Medical Center, Amsterdam and Dr. Debbie Beumer, Prof. Robert van Oostenbrugge and Dr. Wim van Zwam from the Maastricht University Medical Center.

The trialists are represented by Dr. Wim van Zwam, interventional radiologist and head of neuro-interventional radiology at Maastricht University Medical Center.


This initiative is kindly sponsored by the Rolf W. Günther Foundation for Radiological Sciences, www.rwguenther-stiftung.de